Surgeon feedback survey for robotic surgery tools
This study asks surgeons to share their opinions about using robotic systems in surgery. Your feedback could help improve how these tools are used and trained.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a board-certified surgeon.
- You have at least one year of experience with robotic-assisted surgery.
- You are willing to sign a consent form to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at ways to improve how surgeons perform during robot-assisted surgeries. If you are a surgeon who does robotic procedures, joining this study could help make surgery safer and more effective.
This study gathers information from urology patients using digital tools like email or apps. Your feedback could help improve care for others with urology conditions.
This trial studies how well and how efficiently robotic surgery works in both children and adults who need a procedure where robotic surgery is appropriate. It may help surgeons plan safer, smoother operations and improve operating-room efficiency.
This trial tests a robotic training program for newer surgeons. It may help surgeons learn robotic procedures more effectively.
This study surveys Chinese adults to understand their thoughts on robotic surgery, telesurgery, and telemedicine. The results may help improve how these technologies are introduced and explained to patients.
This study looks at how surgeons' bodies are affected when they do surgery using standard laparoscopic (small-incision) tools compared with robotic systems. It compares two types of robotic surgery – one for rectal removal and one for prostate removal – to see which method is less physically stressful for the surgeon.
Hear when a new Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.